Trial · NCT02347059
L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
NCT02347059, Phase 2, Unknown, University of Toronto
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease. Trials, record NCT02347059. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02347059
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
- NCT number
- NCT02347059
- Status
- Unknown
- Phases
- Phase 2
- Enrollment
- 40 participants, estimated
- Lead sponsor
- University of Toronto
- Conditions
- Parkinson's Disease
- Interventions
- L-dopa, Dopamine Agonists (pramipexole, ropirinole)
- First posted
- 2015-01-27
- Last updated
- 2015-01-27
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Severity at 3-month follow up visit after surgery of non-motor symptoms as assessed by the Non-motor Symptoms Scale (NMSS) | 3 months | |
| Secondary | activities of daily living as assessed by the MDS Unified Parkinson's Disease Rating Scale, Activities of daily living section (MDS-UPDRS-II) | 3 months | |
| Secondary | • the severity of motor symptoms, as assessed by the MDS Unified Parkinson's Disease Rating Scale, motor section (MDS-UPDRS-III) | 3 months | |
| Secondary | • motor fluctuations and dyskinesias as assessed by the MDS Unified Parkinson's Disease Rating Scale, part IV (MDS- UPDRS-IV) | 3 months | |
| Secondary | • the quality of life, as assessed by the Parkinson's Disease Questionnaire (PDQ-39) summary index | 3 months | |
| Secondary | • prevalence and severity of depression and apathy as assessed by the Hospital Anxiety Depression Scale (HADS) and the Apathy Evaluation Scale (AES, both self- and informant-rating scales) | 3 months | |
| Secondary | • severity and occurrence of ICDs, as rated with the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP scale) | 3 months | |
| Secondary | • severity and occurrence of sleep disorders, as rated with the Parkinson's disease Sleep Scale (PDSS) | 3 months | |
| Secondary | Safety and tolerability will be assessed by recording the frequency and the severity of reported adverse events during each visit. | 3 months |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02347059
GET https://conductscience.org/api/trials/v1/NCT02347059/registered